跳至主要内容
临床试验/NL-OMON42592
NL-OMON42592已完成不适用

PHYOS: An observational study of patients with Primary Hyperoxaluria type1 - DCR-PH1-501

Dicerna Pharmaceuticals, Inc0 个研究点目标入组 7 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
7

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational invasive

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Diagnosis of PH1, confirmed by genotyping for mutations in the AGXT gene.
  • - Urine oxalate excretion >=0.7 mmol per 1.73 m2 body surface area (BSA) in 24 hours.
  • - Estimated glomerular filtration rate (eGFR) >=40 mL/min per 1.73 m2 BSA.

排除标准

  • - Prior renal and/or hepatic transplantation, or patients undergoing dialysis.
  • - Pregnancy or lactation at the time of screening or enrollment.
  • - Any significant illness, organ system dysfunction, or other condition that, in the opinion of the Investigator, would interfere with the subject*s ability to comply with the protocol requirements, including the ability to attend all visits and undergo all assessments.

研究者

相似试验

PHYOS: An observational study of patients with... | 临床试验